All Stories

  1. Draft Genome Sequence of a Multidrug-Resistant Sequence Type 231 Outbreak-Associated Clone of Klebsiella pneumoniae, KP41-2015, Producing OXA-232 Carbapenemase

    Article • Genome Announcements, July 2017, ASM Journals

    Dr David W Wareham

  2. Draft Genome Sequence of Providencia stuartii PS71, a Multidrug-Resistant Strain Associated with Nosocomial Infections in Greece

    Article • Genome Announcements, March 2017, ASM Journals

    Dr David W Wareham

  3. Rapid Detection of Carbapenemases in Enterobacteriaceae: Evaluation of the Resist-3 O.K.N. (OXA-48, KPC, NDM) Lateral Flow Multiplexed Assay

    Article • Journal of Clinical Microbiology, February 2017, ASM Journals

    Dr David W Wareham

  4. In vitro and in vivo activity of ML302F: a thioenolate inhibitor of VIM-subfamily metallo β-lactamases

    Article • MedChemComm, January 2016, Royal Society of Chemistry

    Dr David W Wareham

  5. Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae

    Article • Journal of Clinical Microbiology, November 2015, ASM Journals

    Dr David W Wareham

  6. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Dr David W Wareham, Dr Lynette Phee

  7. In VitroandIn VivoActivities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, March 2014, ASM Journals

    Dr David W Wareham

  8. Whiter, brighter, and more stable cellulose paper coated with antibacterial carboxymethyl starch stabilized ZnO nanoparticles

    Article • Journal of Materials Chemistry B, January 2014, Royal Society of Chemistry

    Dr David W Wareham, Professor Stephen Malcom Kelly

  9. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii

    Article • BMC Microbiology, January 2014, Springer Science + Business Media

    Dr David W Wareham

  10. In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens

    Article • International Journal of Antimicrobial Agents, October 2013, Elsevier

    Dr David W Wareham

  11. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

    Article • International Journal of Antimicrobial Agents, March 2013, Elsevier

    Dr David W Wareham

  12. Evaluation of rapid E test MIC testing using CHROM agar on lower respiratory tract samples; collected from ICU from patients with suspected Ventilator associated pneumonia

    Article • Journal of Infection, December 2011, Elsevier

    Dr David W Wareham

  13. Epidemiology, antibiotic resistance trends and the cost of enteric fever in East London, 2005–2010

    Article • Travel Medicine and Infectious Disease, July 2011, Elsevier

    Dr David W Wareham

  14. Two new variants of and creation of a repository for Stenotrophomonas maltophilia quinolone protection protein (Smqnr) genes

    Article • International Journal of Antimicrobial Agents, January 2011, Elsevier

    Dr David W Wareham

  15. Antimicrobial activity of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia

    Article • International Journal of Antimicrobial Agents, August 2010, Elsevier

    Dr David W Wareham

  16. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance

    Article • International Journal of Antimicrobial Agents, March 2010, Elsevier

    Dr David W Wareham, Nicola Gordon

  17. Prevalence, nucleotide sequence and expression studies of two proteins of a 5.6kb, Class III, Bacteroides plasmid frequently found in clinical isolates from European countries

    Article • Plasmid, March 2010, Elsevier

    Dr David W Wareham, József Sóki

  18. Nebulised colistin for nosocomial Acinetobacter baumannii respiratory tract infection

    Article • February 2010, Wiley

    Dr David W Wareham

  19. Infections associated with implanted medical devices

    Article • January 2010, Elsevier

    Dr David W Wareham

  20. Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK

    Article • International Journal of Antimicrobial Agents, November 2009, Elsevier

    Dr David W Wareham

  21. Pancreatitis, Diarrhea, and Glycopeptide Dependence

    Article • Infectious Diseases in Clinical Practice, May 2009, Wolters Kluwer Health

    Dr David W Wareham

  22. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005 – 2006

    Article • Annals of Clinical Microbiology and Antimicrobials, June 2008, Springer Science + Business Media

    Dr David W Wareham

  23. A case of febrile neutropenia with a skin rash

    Article • Journal of Infection, April 2008, Elsevier

    Dr David W Wareham

  24. Nebulised colistin for nosocomial Acinetobacter baumannii respiratory tract infection

    Article • October 2007, Wiley

    Dr David W Wareham

  25. A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates

    Article • International Journal of Medical Microbiology, July 2007, Elsevier

    Dr David W Wareham

  26. Herpes zoster

    Article • BMJ, June 2007, BMJ

    Dr David W Wareham

  27. The Dangers of Dog Bites

    Article • Journal of Infection, March 2007, Elsevier

    Dr David W Wareham

  28. Advances in bacterial specific imaging

    Article • Brazilian Archives of Biology and Technology, October 2005, FapUNIFESP (SciELO)

    Dr David W Wareham

  29. The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans – P. aeruginosa pathogenicity model

    Article • FEMS Microbiology Letters, January 2005, Oxford University Press (OUP)

    Dr David W Wareham

  30. Infection imaging with radiopharmaceuticals in the 21st century

    Article • Brazilian Archives of Biology and Technology, September 2002, FapUNIFESP (SciELO)

    Dr David W Wareham

  31. Chloramphenicol in the 21st century

    Article • Hospital Medicine, March 2002, Mark Allen Group

    Dr David W Wareham

  32. Concerns about 99mTc-labelled ciprofloxacin for infection detection

    Article • European Journal of Nuclear Medicine and Molecular Imaging, June 2001, Springer Science + Business Media

    Dr David W Wareham, Dr. Mick Welling

  33. Pneumonitis in an elderly Bangladeshi man

    Article • Journal of Clinical Pathology, June 2001, BMJ

    Dr David W Wareham